Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts

Biochemical and Biophysical Research Communications

Volumn 378, Issue 2, 2009, Pages 218-223

  Kitahara, Kanako ^a   Kusunoki, Natsuko ^a   Kakiuchi, Terutaka ^a   Suguro, Toru ^a   Kawai, Shinichi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; Chemokine; Inflammation; Rheumatoid arthritis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADIPOCYTOKINE; ADIPONECTIN; ADIPONECTIN ANTIBODY; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN ANTIBODY; RESISTIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CHEMOTAXIS; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOREGULATION; METABOLIC REGULATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RECEPTOR GENE; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ADIPONECTIN; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CHEMOTAXIS; FIBROBLASTS; HUMANS; INTERLEUKIN-8; NEUTROPHILS; PROTEIN KINASE INHIBITORS; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION; SYNOVIAL FLUID;

EID: 57049158112     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.017     Document Type: Article

References (28)

1. Dixon W.G., and Symmons D.P. What effects might anti-TNF{alpha} treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNF{alpha} in cardiovascular pathophysiology. Ann. Rheum. Dis. 66 (2007) 1132-1136
2. Tilg H., and Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6 (2006) 772-783
3. Kobashi C., Urakaze M., Kishida M., Kibayashi E., Kobayashi H., Kihara S., Funahashi T., Takata M., Temaru R., Sato A., Yamazaki K., Nakamura N., and Kobayashi M. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ. Res. 97 (2005) 1245-1252
4. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., and Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
5. Otero M., Lago R., Gomez R., Lago F., Dieguez C., Gomez-Reino J.J., and Gualillo O. Changes in plasma levels of fat-derived hormones, adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann. Rheum. Dis. 65 (2006) 1198-1201
6. Schaffler A., Ehling A., Neumann E., Herfarth H., Tarner I., Scholmerich J., Muller-Ladner U., and Gay S. Adipocytokines in synovial fluid. JAMA 290 (2003) 1709-1710
7. Lago F., Dieguez C., Gomez-Reino J., and Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat. Clin. Pract. Rheumatol. 3 (2007) 716-724
8. Toussirot E., Streit G., and Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr. Med. Chem. 14 (2007) 1095-1100
9. Koch A.E., Kunkel S.L., Burrows J.C., Evanoff H.L., Haines G.K., Pope R.M., and Strieter R.M. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J. Immunol. 147 (1991) 2187-2195
10. Mukaida N., Harada A., and Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev. 9 (1998) 9-23
11. Kusunoki N., Yamazaki R., and Kawai S. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Arthritis Rheum. 46 (2002) 3159-3167
12. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31 (1988) 315-324
13. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., Christy W., Cooke T.D., Greenwald R., Hochberg M., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 29 (1986) 1039-1049
14. Lee Y.B., Nagai A., and Kim S.U. Cytokines, chemokines, and cytokine receptors in human microglia. J. Neurosci. Res. 69 (2002) 94-103
15. Luo X.H., Guo L.J., Yuan L.Q., Xie H., Zhou H.D., Wu X.P., and Liao E.Y. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp. Cell Res. 309 (2005) 99-109
16. Frevert C.W., Wong V.A., Goodman R.B., Goodwin R., and Martin T.R. Rapid fluorescence-based measurement of neutrophil migration in vitro. J. Immunol. Methods 213 (1998) 41-52
17. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 26 (2005) 439-451
18. Ehling A., Schaffler A., Herfarth H., Tarner I.H., Anders S., Distler O., Paul G., Distler J., Gay S., Scholmerich J., Neumann E., and Muller-Ladner U. The potential of adiponectin in driving arthritis. J. Immunol. 176 (2006) 4468-4478
19. Tang C.H., Chiu Y.C., Tan T.W., Yang R.S., and Fu W.M. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor AMPK, p38, and NF-kappa B pathway. J. Immunol. 179 (2007) 5483-5492
20. Hoffmann E., Dittrich-Breiholz O., Holtmann H., and Kracht M. Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 72 (2002) 847-855
21. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., Hotta K., Nishida M., Takahashi M., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Funahashi T., and Matsuzawa Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
22. Senolt L., Pavelka K., Housa D., and Haluzik M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 35 (2006) 247-252
23. Serelis J., Kontogianni M.D., Katsiougiannis S., Bletsa M., Tektonidou M.G., and Skopouli F.N. Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin Rheum 27 (2008) 795-797
24. Nishida K., Okada Y., Nawata M., Saito K., and Tanaka Y. Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. Endocr. J. 55 (2008) 213-216
25. Komai N., Morita Y., Sakuta T., Kuwabara A., and Kashihara N. Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod. Rheumatol. 17 (2007) 385-390
26. Kappes A., and Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm. Metab. Res. 32 (2000) 548-554
27. Rovin B.H., and Song H. Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin. Immunol. 120 (2006) 99-105
28. Tsatsanis C., Zacharioudaki V., Androulidaki A., Dermitzaki E., Charalampopoulos I., Minas V., Gravanis A., and Margioris A.N. Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin. Ann. NY Acad. Sci. 1083 (2006) 185-195